{
    "eid": "2-s2.0-85150789915",
    "title": "Does leukocytosis remain a predictive factor for survival outcomes in patients with acute promyelocytic leukemia receiving ATRA plus a chemotherapy-based regimen? A prospective multicenter analysis from TALWG",
    "cover-date": "2023-01-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Hematology",
            "@code": "2720",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "Acute promyelocytic leukemia",
        "APL",
        "Thailand"
    ],
    "authors": [
        "Smith Kungwankiattichai",
        "Weerapat Owattanapanich",
        "Thanawat Rattanathammethee",
        "Ekarat Rattarittamrong",
        "Chantiya Chanswangphuwana",
        "Chantana Polprasert",
        "Wasithep Limvorapitak",
        "Supawee Saengboon",
        "Pimjai Niparuck",
        "Teeraya Puavilai",
        "Jakrawadee Julamanee",
        "Pirun Saelue",
        "Chinadol Wanitpongpun",
        "Kannadit Prayongratana",
        "Chantarapa Sriswasdi",
        "Chajchawan Nakhakes"
    ],
    "citedby-count": 0,
    "ref-count": 35,
    "ref-list": [
        "Immunophenotypic profile of adult acute myeloid leukemia (AML): analysis of 267 cases in Thailand",
        "Very long-term outcome of acute promyelocytic leukemia after treatment with all-trans retinoic acid and chemotherapy: the European APL Group experience",
        "Retinoic acid and arsenic trioxide for acute promyelocytic leukemia",
        "Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trial",
        "The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes",
        "The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia",
        "Risk-adapted treatment of acute promyelocytic leukemia based on all- trans retinoic acid and anthracycline with addition of cytarabine in consolidation therapy for high-risk patients: further improvements in treatment outcome",
        "AIDA 0493 protocol for newly diagnosed acute promyelocytic leukemia: very long-term results and role of maintenance",
        "Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel",
        "Revised recommendations of the international working group for diagnosis, standardization of response criteria, treatment outcomes, and reporting standards for therapeutic trials in acute myeloid leukemia",
        "Scientific subcommittee on disseminated intravascular coagulation (DIC) of the International Society on Thrombosis and Haemostasis (ISTH). Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation",
        "Early death and survival of patients with acute promyelocytic leukemia in ATRA plus arsenic era: a population-based study",
        "Outcomes in adult acute promyelocytic leukemia: a decade experience",
        "Clinico-hematological profile and outcome of acute promyelocytic leukemia patients at a tertiary care center in North India",
        "Acute promyelocytic leukemia: an experience from a tertiary care centre in north India",
        "A modified AIDA protocol with anthracycline-based consolidation results in high antileukemic efficacy and reduced toxicity in newly diagnosed PML/RARalpha-positive acute promyelocytic leukemia. PETHEMA group",
        "Molecular remission in PML/RAR alpha-positive acute promyelocytic leukemia by combined all-trans retinoic acid and idarubicin (AIDA) therapy. Gruppo Italiano-Malattie Ematologiche Maligne dell'Adulto and Associazione Italiana di Ematologia ed Oncologia Pediatrica Cooperative Groups",
        "Single-agent arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia: durable remissions with minimal toxicity",
        "Arsenic trioxide during consolidation for patients with previously untreated low/intermediate risk acute promyelocytic leukaemia may eliminate the need for maintenance therapy",
        "Improved outcomes with retinoic acid and arsenic trioxide compared with retinoic acid and chemotherapy in non-high-risk acute promyelocytic leukemia: final results of the randomized Italian-German APL0406 trial",
        "Disseminated intravascular coagulation in acute promyelocytic leukaemia and its impact on the induction failure: a single centre study",
        "The evaluation of risk factors leading to early deaths in patients with acute promyelocytic leukemia: a retrospective study",
        "Risk factors for early in-hospital death in patients who developed coagulopathy during induction therapy for acute promyelocytic leukemia: a nationwide analysis in Japan",
        "Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHEMA and GIMEMA cooperative groups",
        "The global problem of early deaths in acute promyelocytic leukemia: a strategy to decrease induction mortality in the most curable leukemia",
        "Predictors of early death, serious hemorrhage, and differentiation syndrome in Japanese patients with acute promyelocytic leukemia",
        "Differentiation syndrome in acute promyelocytic leukaemia",
        "Continuing high early death rate in acute promyelocytic leukemia: a population-based report from the Swedish Adult Acute Leukemia Registry",
        "Early death rate in acute promyelocytic leukemia remains high despite all-trans retinoic acid",
        "Acute promyelocytic leukemia: a population-based study on incidence and survival in the United States, 1975\u20132008",
        "Oral tetra-arsenic tetra-sulfide formula versus intravenous arsenic trioxide as first-line treatment of acute promyelocytic leukemia: a multicenter randomized controlled trial",
        "Oral arsenic plus retinoic acid versus intravenous arsenic plus retinoic acid for non-high-risk acute promyelocytic leukaemia: a non-inferiority, randomised phase 3 trial",
        "Oral arsenic and all-trans retinoic acid for high-risk acute promyelocytic leukemia",
        "Efficacy and the adverse effects of oral versus intravenous arsenic for acute promyelocytic leukemia: a meta-analysis of randomized-controlled studies"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60199578",
            "affilname": "Ramathibodi Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199578",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60199575",
            "affilname": "Siriraj Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199575",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Chaing Mai",
            "@id": "60032250",
            "affilname": "Faculty of Medicine, Chiang Mai University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60032250",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Khon Kaen",
            "@id": "60026046",
            "affilname": "Faculty of Medicine, Khon Kaen University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60026046",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Hatyai",
            "@id": "60025527",
            "affilname": "Faculty of Medicine, Prince of Songkia University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60025527",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Pathum Thani",
            "@id": "60013939",
            "affilname": "Faculty of Medicine, Thammasat University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60013939",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60006964",
            "affilname": "Phramongkutklao College of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60006964",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60005255",
            "affilname": "Rajavithi Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60005255",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Editor-in-Chief of Hematology",
        "Thai Society of Hematology",
        "Faculty of Medicine Siriraj Hospital, Mahidol University"
    ]
}